Arkolith/Insider Trading/ZIOP/Form 4

Boyle Kevin S. Sr.

Chief Executive Officer, DirectorZIOPHARM ONCOLOGY INC (ZIOP) · full profile →Form 4 · filed Nov 17, 2021
Net Buying
Open-Market Buys
$14K
Open-Market Sells
$0
Net Open-Market Flow
$14K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2021Buy(P)9K$1.40$13K885K
Nov 16, 2021Buy(P)884$1.40$1K876K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-065138) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML